CORUNDUM SYSTEMS BIOLOGY APPOINTS JESSICA SCHNEIDER AS CHIEF SCIENTIFIC OFFICER
Corundum Systems Biology Expands Operations with New Tokyo Headquarters
Corundum Systems Biology Invests in a Biotech Company Specializing in Improved Reproductive Health for Women
Corundum Systems Biology Invests in a Biotech Firm Focused on Skin Health
Corundum to Sponsor Harvard Chan Microbiome in Public Health Center (HCMPH) Symposium in May
The 2022 Corundum System Biology Award Recipient Announced at IHMC KOBE 2022
Corundum Systems Biology Participates in Raising Concerto Biosciences Series A Funding
On OIST’s Global Bioconvergence Center of Innovation
A Statement from Corundum System Biology Inc. in Advance of the International Human Microbiome Consortium Congress
Corundum Systems Biology to Sponsor Microbiome Study at University of Wisconsin’s Center for Healthy Minds
OIST and Corundum Systems Biology to Jointly Establish Fully Automated Multi-omics & Microbiome Data Analysis Lab
Holobiome Wins USD 1 Million in Research Funding from CSB to Advance Microbiome: Solutions for Pain
Corundum Systems Biology Participates in Axial Therapeutics’ Series C Financing
Corundum Systems Biology Invests to Support US Startup Holobiome
Research to Pave Way for Development of Microbiome-Based Therapies for Atopic Dermatitis
International Online-Workshop on “Potential of microbiome application in the society faced with super-aging population and novel infectious diseases”
Japan’s Corundum Systems Biology to Invest in Health for life Capital Il™ Fund. Forms Strategic Partnership for Japan with the Fund’s Seventure Partners
Japan Company Launches a €20 Million Fund in Microbiome Weizmann Institute’s Professor Eran Segal Joins Its Scientific Advisory Board
